Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

641
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
641
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

32
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
32
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

42
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
42
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

90
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
90
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

39
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
39
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

133
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
133

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

International development of a lupus-specific instrument to assess cognitive symptoms in patients with SLE: Lupus Brain Fog Severity Scale (LBFSS) study.

Lupus science & medicine·2026
Same author

Quality and pratical determinants in [<sup>99m</sup>Tc]Tc-tetrofosmin preparation: hygrometry, syringe sorption & maximal activity per kit.

EJNMMI radiopharmacy and chemistry·2026
Same author

"It was red, it was inflamed": A qualitative study of patient perspectives on musculoskeletal ultrasound in rheumatoid arthritis care.

Patient education and counseling·2026
Same author

Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world study.

RMD open·2026
Same author

Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrument.

Orphanet journal of rare diseases·2026
Same author

Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series.

Annals of the rheumatic diseases·2026

Related Experiment Video

Updated: Sep 23, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

551

Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation study.

Aurelien Schlencker1,2, Laurent Messer3, Marc Ardizzone4

  • 1Service de Rhumatologie, Hôpitaux universitaires de Strasbourg, Strasbourg, France.

Lupus Science & Medicine
|May 14, 2022
PubMed
Summary

Systemic lupus erythematosus (SLE) patient care faces delays and fragmented management. This study identified key disruptions and developed a framework to optimize patient pathways for better SLE outcomes.

Keywords:
autoimmune diseasespatient care teampsychologyqualitative researchsystemic lupus erythematosus

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.9K
A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.4K

Related Experiment Videos

Last Updated: Sep 23, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

551
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.9K
A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
05:01

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information

Published on: July 1, 2020

3.4K

Area of Science:

  • Rheumatology
  • Health Services Research
  • Patient Pathway Analysis

Background:

  • Systemic lupus erythematosus (SLE) presents significant challenges including diagnostic delays and uncoordinated care.
  • Optimizing patient pathways is crucial for improving clinical and organizational management of SLE.

Purpose of the Study:

  • To investigate patient pathways in SLE.
  • To identify and address clinical and organizational challenges in SLE management.
  • To develop a framework for improving individual patient pathways in SLE.

Main Methods:

  • Cross-sectional study involving patients, healthcare providers, and stakeholders.
  • Focus groups to identify impactful disruption points in SLE patient pathways.
  • Development and validation of a novel framework through a stakeholder consensus meeting.

Main Results:

  • Six thematic clusters of disruption were identified, including referral strategies, diagnostic consultations, individualized care coordination, patient education, complication prevention, and support.
  • A consensus was reached on these attributes among stakeholders.
  • A framework for optimizing SLE patient pathways was developed.

Conclusions:

  • Significant disruption points in SLE patient pathways have been identified.
  • A novel conceptual framework has been developed to enhance individual patient pathways in SLE.
  • The findings are relevant for patients, physicians, health organizations, and policymakers.